7/103 sources · 3 publishersUpdated Oct 17, 21:05 UTC
Rocket Lab Shares Slide After Neutron Delay and KeyBanc Target Cut
Rocket Lab delayed the debut of its Neutron rocket to 2027 because of manufacturing issues, sending its shares down 10%. KeyBanc reduced its price target to $100 from $135 while retaining an Overweight rating. Rocket Lab’s second-quarter revenue increased 62% to $234M and its backlog grew 137% to $2.36B, but the stock later fell to $50.8, more than 66% below its yearly peak.
Why it matters
The delay could push out Neutron-related revenue and increase costs for Rocket Lab. KeyBanc’s lower target reflects reduced forecasts and valuation multiples after the launch setback, although the firm kept its Overweight rating.
Key facts
- 1KeyBanc cut its Rocket Lab price target to $100 from $135 and kept an Overweight rating. finance.yahoo.com
- 2Rocket Lab’s Neutron debut was delayed to 2027 because of manufacturing issues. finance.yahoo.com
- 3Rocket Lab shares fell to $50.8, more than 66% below their yearly peak. benzinga.com
- 4Second-quarter revenue rose 62% to $234M, while backlog increased 137% to $2.36B. benzinga.com
Open questions
- cites a $104 billion revenue backlog, while reports a $2.36B backlog; the materials do not reconcile these figures.
Summary written by AlphAI AI Desk from 3 of 3 sources. Not investment advice. Figures are as stated by the linked sources.